1 / 25

Ovarian cancer

Ovarian cancer. Malcolm Padwick MD FRCOG Gynaecology Cancer Surgeon . gynaecology.me.uk. Overview. 6900 cases per year in UK 1 in 75 women 5 th most common cancer in women Half are over 65 75% mortality. Google top hit today.

Download Presentation

Ovarian cancer

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.


Presentation Transcript

  1. Ovarian cancer Malcolm Padwick MD FRCOG Gynaecology Cancer Surgeon gynaecology.me.uk

  2. Overview 6900 cases per year in UK 1 in 75 women 5th most common cancer in women Half are over 65 75% mortality

  3. Google top hit today Cancer missed 20 times: Sue's horrifying story shows how bad ... 25 Feb 2009 ... While this may sound like an horrific one-off, Sue's story is far from unique. The charity Target Ovarian Cancer, which has just committed ...www.dailymail.co.uk/.../Cancer-missed-20-times-Sues-horrifying-story-shows-bad-doctors-STILL-spotting-silent-killer.html - Similar

  4. symptoms Bloated abdomen Full after starting to eat Weight loss Nausea and indigestion Pelvic pain Change in bowel habit Frequency of urine Backache Swollen ankles Abdominal mass Vaginal bleeding

  5. NICE guidelines 2011 Primary care : 2 week wait referral if physical examination identifies ascites and/or pelvic mass not caused by known fibroids. No need to wait for investigations.

  6. NICE guidelines 2011 Primary care : investigate women, especially if over 50 yrs, if they report any of the following symptoms on a persistent or frequent basis.

  7. NICE guidelines 2011 Persistent abdominal distention (bloating) Feeling full – early satiety and/or loss of appetite Pelvic or abdominal pain Increased urinary frequency and/or urgency Unexplained weight loss fatigue or change in bowel habit Women over 50 yrs with new diagnosis of IBS

  8. NICE guidelines 2011 Primary care : First tests Serum CA125 If CA125 > 35 IU/ml Pelvic and abdominal ultrasound If CA125 or USS negative investigate for other causes and ask patient to return if symptoms become more frequent or persistent

  9. misdiagnosis Gastric or peptic ulcers (GI referral) Gallstones (surgeons) Diverticulitis (colorectal) Cystitis (urology) SOB pleural effusion/ PE (chest physician)

  10. prognosis Survival rate by Stage 1 90% 2 60% to 70% 3 15% to 35% 4 5% to 15% Latest data shows 50 % women alive at 5 yrs with stage 3 or 4 disease

  11. Screening Ca125 85% of women with cancer have a raised CA125 But only 50% of women with early stage cancer have a raised CA125 Ca125 is raised in benign conditions

  12. Screening USS Vaginal ultrasound Accurate but high rate of false positives Relatively expensive

  13. screening No general screening available in UK Selective screening for high risk individuals – more than two affected direct relatives BRAC 1 and 2 High risk screening not officially recommended but has acceptance Consider preventative surgery

  14. Making a diagnosis New symptoms in otherwise fit women Postmenopausal – especially > 65 yrs A large mass in a woman with minimal or new symptoms is likely to be ovary/uterus New diagnosis of IBS after 40 yrs is rarely correct ! USS is single most useful investigation

  15. USS Good quality community based service ?? Wait to select correct specialty service – getting this wrong can generate major delays What is the danger in finding coincidental benign disease ?

  16. BSO can be day surgery

  17. Ovplex 362 plasma samples from women with ovarian cancer (n=150) and healthy controls (n=212) were used to develop a multivariate classification model incorporating five plasma biomarkers associated with ovarian cancer. Based upon the measurement of these 5 markers, the model calculates the likelihood that a patient has ovarian cancer

  18. news Do not use Ca125 for follow up patients

  19. news HRT increases risk of epithelial ovarian cancer

  20. news Delayed surgery now accepted

  21. news Intraperitoneal chemotherapy

  22. news Science News Personalized Treatment for Ovarian Cancer ScienceDaily (Nov. 17, 2010) — Researchers have shown that point mutations -- mis-spellings in a single letter of genetic code -- that drive the onset and growth of cancer cells can be detected successfully in advanced ovarian cancer using a technique called OncoMap. The finding opens the way for personalised medicine in which every patient could have their tumour screened, specific mutations identified, and the appropriate drug chosen to target the mutation and halt the growth of their cancer.

  23. news Ultra radical cyto-reductive surgery Diaphragmatic stripping Liver resection Splenectomy Coeliac axis lymph node dissection

  24. The message Treatment is effective but only if we can catch the disease early enough Treatment is more about living a good quality of life with the disease rather than cure

More Related